Skip to content
2000
Volume 19, Issue 7
  • ISSN: 1389-2037
  • E-ISSN: 1875-5550

Abstract

Sarcopenia, the progressive and generalized loss of skeletal muscle mass and strength/function associated with aging, increases the risk of a vast array of adverse health outcomes, including falls, morbidity, loss of independence, disability, and mortality. As such, sarcopenia poses a huge socioeconomic burden in developed countries. The development and implementation of effective interventions against sarcopenia are therefore a public health priority. A preliminary, fundamental step in such a process entails the agreement of researchers, healthcare professionals and policymakers around a unique operational definition of sarcopenia. This will facilitate the framing of a clear clinical entity to be incorporated in standard practice, the understanding of the underlying pathophysiology, and the identification of biological targets for drug development.

Loading

Article metrics loading...

/content/journals/cpps/10.2174/1389203718666170607113459
2018-07-01
2025-05-17
Loading full text...

Full text loading...

/content/journals/cpps/10.2174/1389203718666170607113459
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test